CROMA-PHARMA GmbH, a pharmaceutical company, develops, manufactures, and distributes products in aesthetic dermatology field. The company offers injectable gels based on hyaluronic acid of non-animal origin for non-surgical beauty treatments and aesthetic indications, such as the correction of facial wrinkles and folds, lines, cutaneous depressions, facial contours, and the creation of volume. It also offers skincare products, which include hyaluron based day and night creams, serums, body lotions, face masks, moisturizing gels, anti-ageing serums, and essence recovery products; and lift products, such as a line of sutures for lifting and revitalizing effect, and a line of lifting threads ma...
Founded in 1976
43 22 62 684 68 0
43 22 62 684 68 165
Croma-Pharma Mulls IPO
May 9 14
Croma-Pharma Gmbh is considering an initial public offering (IPO) in 3-5 years, according to WirtschaftsBlatt which cited one of the owners, Andreas Prinz.
Croma-Pharma Gmbh Announces the Signing of Distribution Agreement with Hugel Inc
Apr 1 14
Croma-Pharma Gmbh announced the signing of a 10 year distribution agreement with Hugel Inc. CROMA-PHARMA will become the exclusive Distribution Partner and will be responsible for conducting the required clinical trials and studies. CROMA-PHARMA expects to invest an estimated two-digit million Euro amount for conducting these studies. Following the final approval of FDA, EMA and other authorities, CROMA-PHARMA will then market the new products in Europe, North America and Oceania markets. CROMA-PHARMA will promote the new products under their own brand. Products shall enter the markets in 2018. Forecast of sales until 2021 estimate returns of more than EUR 100 million in this dynamically growing market.